Cohance promoters release 57.49% stake encumbrance

Promoters Berhyanda Limited and Jusmiral Holdings Limited have released the encumbrance over their combined 57.49% stake in Cohance Lifesciences Limited following the full repayment of notes on June 16, 2026. The release covers 219,930,170 equity shares, representing the entire shareholding of the promoters in the company, and is effective from June 16, 2026. The encumbrance was previously created through covenants and offshore pledge agreements under a Notes Purchase Agreement dated May 29, 2024.

The covenants had imposed restrictions on the disposal of shares and the maintenance of financial ratios. CSCGlobal Capital Markets (Singapore) Pte. Ltd. acted as the security agent for the transaction. The disclosure confirms that no direct encumbrance was created over the equity shares of the target company by the shareholders of the borrowers. The total equity share capital of the company stands at 382,567,140 equity shares of Rs. 1/- each, with total diluted share capital at 392,403,586 equity shares.

Details of Released Encumbrance

The following table outlines the shareholding details for the promoters following the release:

Promoter	Promoter Holding	% of Total Share Capital	Released Shares	% of Released Shares	Date of Release
Jusmiral Holdings Limited	92,390,578	24.15%	92,390,578	24.15%	June 16, 2026
Berhyanda Limited	127,539,592	33.34%	127,539,592	33.34%	June 16, 2026

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.92%	-4.16%	-5.19%	-23.37%	-59.80%	-15.38%

Cohance Lifesciences Limited has accepted the resignation of Mr. Himanshu Agarwal from the positions of Whole-time Director and Chief Financial Officer (Key Managerial Personnel). His resignation is effective from the close of business hours on September 13, 2026. Agarwal is leaving the organisation to pursue a new professional opportunity outside the company.

The disclosure was made to the stock exchanges on June 17, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that there are no other material reasons for the resignation other than the career advancement opportunity cited by Agarwal.

Resignation Details

The transition follows a formal resignation email submitted by Agarwal to the Chairman of the Board of Directors & CEO. In his communication, Agarwal expressed gratitude to the Board and leadership team for their support during his tenure. He affirmed his commitment to ensuring an orderly handover of responsibilities and supporting the management in the onboarding of his successor before his departure.

The table below outlines the key regulatory disclosures regarding the change in the company's leadership:

Disclosure Requirement	Details
Reason for change	Resignation of Mr. Himanshu Agarwal (DIN-06672915), Whole-time Director and Chief Financial Officer (Key Managerial Personnel)
Date of cessation	Close of business hours on 13 September 2026
Brief profile	Not Applicable
Disclosure of relationships	Not Applicable